Divestiture

Axe Compute names Kyle Okamoto President, a strategic hire signaling a major push to solve the AI 'distribution problem' and challenge hyperscaler dominance.

Sigma Nursing and Johnson & Johnson launch a new, free program to equip nurses with psychological tools for disaster response, aiming to combat burnout.

After a years-long fight, a major airline caterer admits to violating worker rights, settling a key NLRB case and revealing a pattern of abuses.

USBC divests its sensor business to fully focus on tokenized deposits, a bold pivot into the risky but potentially revolutionary future of digital finance.

As new federal loan limits loom, a unique partnership offers a financial lifeline to future doctors, aiming to combat the growing physician shortage.

A new docuseries from Mrs. Meyer's Clean Day and Hilton Carter shows how community gardens are tackling a national crisis of connection one seed at a time.

Lipocine's stock plummets after its PPD drug fails a Phase 3 trial, but a promising signal in a patient subset offers a narrow path forward.

Arcosa sheds its cyclical barge business for $450M to double down on high-growth construction materials, signaling a major shift to capitalize on U.S. infrastructure.

With a massive profit jump, Vancity doubles down on community investment and branch expansion, challenging the Canadian banking industry's current trends.

The investment firm reports a 213% revenue surge after a major acquisition, but a 'going concern' note raises questions about its financial footing.

A new CMS pilot program allows CBD for Medicare patients at no cost, sparking a race among suppliers like High Tide's NuLeaf Naturals to enter the market.

Celebrating its 90th year, Goya Foods donated 1 million pounds of food, reaffirming its long-standing commitment to fighting a growing hunger crisis.

For 30 years, a nonprofit has awarded millions in educational aid. See how Alliance Direct Benefits’ unique membership model is shaping student futures.

Nexera Technologies reports 23% revenue growth while executing a bold strategic shift from online retail to the high-stakes AI homeland security market.

The biopharma firm touts transformative drug data ahead, but with cash for only month-to-month operations, its future hangs by a precarious thread.

Facing a severe cash crunch and delisting threats, the biotech firm is halting development and seeking buyers for its innovative cancer drug pipeline.

Investors eye Amerant Bancorp's Q1 results for signs of a turnaround after a challenging Q4 and a recent leadership change. Will its new strategy pay off?

NewBeauty's 16th annual awards spotlight 395 winners, signaling a major shift towards science-backed efficacy and holistic health in the beauty market.

As new federal work rules threaten Medicaid for millions, a tech firm offers states free AI logic to identify and protect the medically frail.

Vaso Corporation posts a record $89.1M revenue for 2025, fueled by its GE HealthCare partnership after divesting its healthcare IT unit.